# FDA Inspection 822142 - Saint Mary Medical Center Blood Bank - March 12, 2013

Source: https://www.keypedia.com/records/fda_inspections/saint-mary-medical-center-blood-bank/1022ac3e-1922-427b-96dd-d0d901efe750
Source feed: FDA_Inspections

> FDA Inspection 822142 for Saint Mary Medical Center Blood Bank on March 12, 2013. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 822142
- Company Name: Saint Mary Medical Center Blood Bank
- Inspection Date: 2013-03-12
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 732575 - 2011-06-30](https://www.keypedia.com/records/fda_inspections/saint-mary-medical-center-blood-bank/6f836a96-3cce-49e9-b662-c604c95eb449)
- [FDA Inspection 546564 - 2008-11-06](https://www.keypedia.com/records/fda_inspections/saint-mary-medical-center-blood-bank/ac361eaf-e219-4c6a-a907-c238324d69aa)

Company: https://www.keypedia.com/companies/saint-mary-medical-center-blood-bank/bad0a051-fc68-402f-bba4-eff0ae12e88b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d